Insights into Chinese prostate cancer with RNA-seq

Cell Research

Volumn 22, Issue 5, 2012, Pages 786-788

  Sahu, Anirban ^a   Iyer, Matthew K ^a   Chinnaiyan, Arul M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENE FUSION; HUMAN; MALE; METABOLISM; PROSTATE TUMOR; SEQUENCE ANALYSIS;

GENE FUSION; HUMANS; MALE; PROSTATIC NEOPLASMS; SEQUENCE ANALYSIS, RNA;

EID: 84862001441     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2012.50     Document Type: Article

References (16)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90.
2. Shao Q, Ouyang J, Fan Y, et al. Prostate cancer in the senior men from rural areas in east district of China: Contemporary management and 5-year outcomes at multi-institutional collaboration. Cancer Lett 2012; 315:170-177.
3. Squire JA, Park PC, Yoshimoto M, et al. Prostate cancer as a model system for genetic diVersity in tumors. AdV. Cancer Res. 2011; 112:183-216.
4. Tomlins SA, Rhodes DR, Perner S, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005; 310:644-648.
5. Tomlins SA, Laxman B,Varambally S, et al. Role of the TMPRSS2-ERG gene fusion in prostate cancer. Neoplasia 2008; 10:177-188.
6. Magi-Galluzzi C, Tsusuki T, Elson P, et al. TMPRSS2-ERG gene fusion preValence and class are significantly different in prostate cancer of Caucasian, African- American and Japanese patients. Prostate 2011; 71:489-497.
7. Lee K, Chae JY, Kwak C, et al. TMPRSS2-ERG gene fusion and clinicopathologic characteristics of Korean prostate cancer patients. Urology 2010; 76:1268.e7-e13.
8. Mao X, Yu Y, Boyd LK, et al. Distinct genomic alterations in prostate cancers in Chinese and Western populations suggest alternatiVe pathways of prostate carcinogenesis. Cancer Res 2010; 70:5207-5212.
9. Liu F, Hsing AW, Wang X, et al. Systematic confirmation study of reported prostate cancer risk-associated single nucleotide polymorphisms in Chinese men. Cancer Sci 2011; 102:1916-1920.
10. Wang M, Liu F, Hsing AW, et al. Replication and cumulatiVe effects of GWAS-identified geneticVariations for prostate cancer in Asians: D case-control study in the ChinaPCa consortium. Carcinogenesis 2012; 33:356-360.
11. Prensner JR, Iyer MK, Balbin OA, et al. Transcriptome sequencing across a prostate cancer cohort identifies PCAT- 1, an unannotated lincRNA implicated in disease progression. Nat Biotchnol 2011; 29:742-749.
12. Wang Z, Gerstein M, Snyder M. RNASeq: D reVolutionary tool for transcriptomics. Nat. ReV. Genet. 2009; 10:57-63.
13. Ren S, Peng Z, Mao JH, et al. RNAseq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternatiVe splicing. Cell Res 2012; 22:806-821.
14. Chen JH, He HC, Jiang FN, et al. Analysis of the specific pathways and networks of prostate cancer for gene expression profiles in the Chinese population.V 2011 Oct 30. doi:10.1007/s12032-011-0088-5
15. Pflueger D, Terry S, Sboner A, et al. DiscoVery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing. Genome Res 2011; 21:56-67.
16. Maher CA, Kumar-Sinha C, Cao X, et al. Transcriptome sequencing to detect gene fusions in cancer. Nature 2009; 458:97-101.